Related Experiment Video
Updated: Mar 5, 2026

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
10.1K
Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous
AJNR. American Journal of Neuroradiology
|March 26, 2017
Summary
Diagnosing glioma recurrence is challenging. Simultaneous FDG-PET/MR imaging provides multiparametric assessment, combining MR imaging and PET parameters to significantly improve the accuracy of detecting glioma recurrence.
Area of Science:
- Neuroimaging
- Oncology
- Radiology
Background:
- Differentiating glioma recurrence from treatment-induced necrosis is difficult with conventional imaging.
- Functional MR imaging and PET parameters offer potential for improved diagnostic accuracy.
Purpose of the Study:
- To assess the diagnostic performance of individual and combined functional MR imaging and PET parameters using simultaneous FDG-PET/MR imaging.
- To evaluate the utility of these parameters in detecting suspected glioma recurrence.
Main Methods:
- Thirty-five treated glioma patients with 41 enhancing lesions underwent simultaneous FDG-PET/MR imaging.
- Calculated parameters included relative cerebral blood volume (rCBV), apparent diffusion coefficient (ADC), choline to creatine ratio (Cho/Cr), and target-to-background ratios (TBR).
- Receiver operating characteristic (ROC) analysis was used to determine diagnostic performance individually and in combination.
Main Results:
- Individual parameters showed significant detection capabilities for recurrent lesions.
- The combination of MR imaging parameters (ADCmean and Cho/Cr) with a PET parameter (mean TBR) achieved the highest diagnostic accuracy with an area under the curve of 0.935 ± 0.046.
- Multivariate analysis combining all MR imaging parameters yielded an area under the curve of 0.913 ± 0.053.
Conclusions:
- Simultaneous FDG-PET/MR imaging enables a multiparametric assessment of glioma recurrence.
- This approach offers synergistic benefits, increasing diagnostic accuracy and clinical utility for suspected glioma recurrence.
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
